AtriCure, Inc. (ATRC) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — ATRC

Balance Sheet

(in millions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	167.79	146.17	147.87	117.80	99.89	130.34	106.04	64.97	80.60	67.24	77.34	48.82	54.56	28.14	39.89	67.62	85.38
Short-term Investments	--	--	--	--	--	0.00	7.99	40.99	52.42	59.79	58.52	73.82	63.90	83.26	79.86	92.25	141.82
Accounts Receivable	79.98	71.31	62.98	66.00	63.32	54.91	55.57	55.32	51.53	48.36	45.66	41.47	41.49	40.88	33.50	33.84	29.74
Inventory	83.93	81.14	78.95	76.34	74.91	76.55	73.65	71.94	61.89	55.41	48.85	43.95	41.29	40.76	38.59	37.61	36.14
Total Current Assets	345.53	313.69	301.11	271.26	251.48	269.29	252.85	245.23	252.72	237.98	238.33	212.29	206.17	199.61	195.71	235.94	298.30
Property, Plant & Equipment	42.42	39.74	39.55	40.68	41.24	43.54	42.18	42.04	41.40	40.54	39.61	8.03	7.98	8.32	8.74	9.08	9.25
Goodwill	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78	234.78
Intangible Assets	43.26	45.64	50.14	52.25	54.36	58.35	60.24	62.12	65.68	67.38	38.60	40.08	41.05	42.02	43.96	44.93	1.64
Total Non-current Assets*	331.11	330.30	334.33	337.59	340.15	345.78	344.42	346.40	347.55	356.20	344.78	369.63	381.22	385.38	417.26	465.13	401.60
Total Assets	676.64	643.99	635.44	608.85	591.63	615.07	597.27	591.63	600.27	594.17	583.10	581.91	587.39	584.98	612.97	701.08	699.90
Accounts Payable	35.85	30.56	25.47	25.68	25.18	31.74	26.67	28.99	24.54	23.71	23.56	24.41	23.72	20.29	17.53	16.50	15.46
Total Current Liabilities	81.92	73.19	77.84	68.84	61.22	74.43	61.23	61.25	82.54	71.41	62.47	57.60	56.32	47.38	53.95	67.43	58.46
Long-term Debt	61.00	61.00	61.87	61.87	61.87	61.87	61.87	61.87	60.00	60.00	60.00	60.00	60.00	60.00	60.00	60.00	60.00
Total Non-current Liabilities*	78.29	79.10	81.10	75.52	75.79	75.62	73.96	74.06	54.90	60.34	65.78	74.01	74.36	74.78	70.55	248.56	250.20
Total Liabilities	160.21	152.29	158.94	144.36	137.01	150.05	135.19	135.32	137.44	131.75	128.26	131.60	130.68	122.16	124.50	315.99	308.66
Retained Earnings	(404.14)	(413.09)	(414.96)	(414.69)	(408.50)	(386.19)	(378.33)	(370.33)	(347.27)	(338.21)	(333.09)	(322.45)	(310.18)	(295.34)	(266.41)	(363.52)	(347.27)
Total Stockholder Equity	516.43	491.69	476.51	464.49	454.62	465.02	462.09	456.31	462.83	462.42	454.85	450.31	456.71	462.83	488.47	385.08	391.24

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	153.60	141.25	140.50	134.27	136.14	123.62	124.28	115.91	116.27	108.85	106.54	98.29	100.92	93.49	88.03	83.25	84.53	74.58	--	70.46
Cost of Revenue	34.98	31.94	35.16	32.94	34.66	30.99	31.66	29.12	29.43	27.58	26.73	24.42	23.84	23.89	22.92	21.53	21.01	18.98	18.20	18.23
Gross Profit	118.63	109.31	105.34	101.33	101.48	92.63	92.62	86.79	86.84	81.27	79.82	73.87	77.08	69.61	65.11	61.71	63.52	55.60	55.02	52.23
Research & Development	26.40	24.24	24.51	22.89	29.28	22.53	34.96	20.96	20.42	19.85	20.80	20.35	17.44	15.33	13.75	15.17	14.79	13.63	13.81	11.28
Selling, General & Admin	82.56	84.55	78.34	78.23	78.39	76.05	72.19	73.24	73.60	72.34	67.69	61.60	63.78	60.06	55.50	57.27	62.39	56.12	48.61	49.87
Total Operating Expenses	108.96	108.79	102.85	101.12	107.67	98.58	107.14	94.20	94.01	92.19	88.48	81.96	81.22	75.39	69.25	72.44	77.18	69.75	67.52	(46.44)
Operating Income	9.66	0.53	2.49	0.21	(6.19)	(5.95)	(14.52)	(7.40)	(7.17)	(10.92)	(8.67)	(8.09)	(4.14)	(5.78)	(4.14)	(10.72)	(13.66)	(14.15)	(12.50)	98.67
Interest Expense	--	--	--	--	--	--	--	--	--	1.68	1.80	1.77	1.72	1.64	1.56	1.32	1.10	1.00	1.08	1.45
Pretax Income	9.43	0.39	2.36	(0.09)	(5.93)	(6.51)	(15.30)	(7.53)	(7.75)	(13.09)	(9.42)	(9.01)	(5.03)	(6.40)	(4.05)	(12.23)	(14.80)	(15.13)	(13.69)	97.15
Tax Provision	0.47	0.29	0.60	0.18	0.26	0.24	0.27	0.32	0.25	0.18	0.37	0.05	0.09	0.08	0.12	0.05	0.05	0.06	0.05	0.04
Net Income	8.96	0.11	1.76	(0.27)	(6.19)	(6.75)	(15.57)	(7.85)	(8.01)	(13.27)	(9.79)	(9.05)	(5.12)	(6.48)	(4.17)	(12.27)	(14.84)	(15.18)	(13.74)	97.11
Basic EPS	0.18	0.00	0.04	(0.01)	(0.13)	(0.14)	(0.33)	(0.17)	(0.17)	(0.28)	(0.21)	(0.20)	(0.11)	(0.14)	(0.10)	(0.27)	(0.32)	(0.33)	(0.31)	2.15
Diluted EPS	0.18	0.00	0.04	(0.01)	(0.13)	(0.14)	(0.33)	(0.17)	(0.17)	(0.28)	(0.21)	(0.20)	(0.11)	(0.14)	(0.10)	(0.27)	(0.32)	(0.33)	(0.30)	2.11

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	22.19	(4.00)	20.03	26.72	21.62	(11.03)	5.84	20.00	7.38	(21.02)	4.03	1.52	3.01	(4.08)	0.05	(1.78)	4.23	(24.63)	0.30	(0.23)
Capital Expenditures	3.77	3.85	1.60	2.61	2.66	2.18	2.69	3.61	2.38	2.77	2.79	3.63	3.08	2.50	4.17	5.15	4.18	3.38	2.71	1.50
Free Cash Flow*	18.43	(7.85)	18.43	24.11	18.95	(13.21)	3.14	16.40	5.00	(23.79)	1.24	(2.11)	(0.07)	(6.58)	(4.12)	(6.93)	0.05	(28.01)	(2.41)	(1.74)
Investing Cash Flow	(3.77)	(3.85)	(2.60)	(2.60)	(7.66)	(1.68)	(14.69)	4.39	30.89	9.64	(2.79)	11.87	(16.08)	28.81	7.00	(3.24)	20.52	19.72	1.08	(25.10)
Financing Cash Flow	3.26	(13.25)	2.10	5.98	3.42	(10.32)	1.74	(0.33)	2.85	(7.86)	2.36	0.13	2.99	(5.52)	1.98	(0.40)	1.86	(10.50)	2.51	(2.26)

* Derived from reported values